CQ Medical

Executive Summary

CQ Medical is a San Diego-based medical device company specializing in patient positioning systems for radiotherapy, including photon, proton, SRS/SRT, and brachytherapy. Founded in 2015, the company differentiates itself through its 'Care Quotient' philosophy, combining emotional intelligence with technical innovation to improve patient outcomes in oncology. With a focus on precision and comfort, CQ Medical's products are used in leading cancer treatment centers globally. As a private company, it has not publicly disclosed funding or valuation, but its established presence in the radiotherapy market positions it for steady growth within the expanding oncology device sector. Looking ahead, CQ Medical is well-positioned to capitalize on the increasing adoption of advanced radiotherapy techniques. The company's growth prospects hinge on its ability to innovate and expand its product portfolio, particularly in emerging areas like FLASH radiotherapy and MR-guided systems. While no specific financial or regulatory milestones are available, the demand for better patient immobilization and positioning solutions is rising with the complexity of modern treatments. The company's private status limits visibility, but its niche expertise and established customer base provide a solid foundation for future expansion.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation proton therapy positioning system70% success
• Q4 2026Strategic partnership with a major cancer center for clinical validation60% success
• Q1 2027Launch of a FLASH radiotherapy-compatible positioning product50% success